Rankings
▼
Calendar
KURA Q1 2016 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena
KURA
Kura Oncology, Inc.
$774M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.36
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$490,000
Balance Sheet
Total Assets
$80M
Total Liabilities
$4M
Stockholders' Equity
$76M
Cash & Equivalents
$16M
← FY 2016
All Quarters
Q2 2016 →
